Authors:
Ysebaert, L
Carli, PM
Casasnovas, RO
Girodon, F
Caillot, D
Mugneret, F
Maynadie, M
Citation: L. Ysebaert et al., Minimally differentiated acute myeloid leukemia (AML-M0) with lymphoid presentation at relapse: a case report, LEUKEMIA, 15(10), 2001, pp. 1673-1674
Authors:
Bene, MC
Bernier, M
Casasnovas, RO
Castoldi, G
Doekharan, D
van der Holt, B
Knapp, W
Lemez, P
Ludwig, WD
Matutes, E
Orfao, A
Schoch, C
Sperling, C
van't Veer, MB
Citation: Mc. Bene et al., Acute myeloid leukaemia MO: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients, BR J HAEM, 113(3), 2001, pp. 737-745
Authors:
Solary, E
Mannone, L
Moreau, D
Caillot, D
Casasnovas, RO
Guy, H
Grandjean, M
Wolf, JE
Andre, F
Fenaux, P
Canal, P
Chauffert, B
Wotawa, A
Bayssas, M
Gennes, P
Citation: E. Solary et al., Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes, LEUKEMIA, 14(12), 2000, pp. 2085-2094
Authors:
Casasnovas, RO
Haioun, C
Dumontet, C
Gabarre, J
Richard, B
Lederlin, P
Caillot, D
Stamatoullas, A
Morel, P
Quesnel, B
Blay, JY
Bouabdallah, K
Gisselbrecht, C
Citation: Ro. Casasnovas et al., Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas, HAEMATOLOG, 85(5), 2000, pp. 502-507